Navigation Links
Benda Pharmaceutical Reports Third Quarter 2008 Financial Results
Date:11/18/2008

esearch and development expenses (249,357) (310,084) (79,576) (212,965) Total operating expenses (7,934,157) (13,030,427) (1,811,924) (2,050,956) Operating income / (loss) (684,494) (5,340,525) 608,970 1,738,208 Interest income / (expenses) (3,339,457) (2,207,878) (998,877) (1,141,472) Other income (expenses) 10,140 113,364 (237,918) 23,206 Government subsidies / grants -- 1,690,974 -- 1,417,859 Income / (loss) before minority interest and income taxes (4,013,811) (5,744,065) (627,825) 2,037,801 Income taxes (907,176) -- (382,368) -- Minority interest 256,486 (1,525,486) 168,270 (1,058,870) Net income / (loss) $(4,664,501) $(7,269,551) $(841,923) $978,931 Earnings / (loss) per share - basic $(0.05) $(0.08) $(0.01) $0.01 Weighted average shares outstanding - basic 100,887,853 96,872,524 101,556,376 97,359,178 Earnings / (loss) per share - diluted $(0.05) $(0.06) $(0.01) $0.01 Weighted average shares outstanding - diluted 100,887,853 125,103,425 101,556,376 131,377,347 Benda Pharmaceutical, Inc., Balance Sheet (In thousands, except share and per share data) September 30 December 31 2008 2007 (Unaudited) Assets Current Assets Cash and cash equivalents $1,685,375 $1,266,240 Trade receivables, net 11,895,149 10,472,233 Other receivables
'/>"/>
SOURCE Benda Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Benda Pharmaceutical Files Amendment To Form S-1
2. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
3. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
4. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
5. ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
6. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
7. Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
10. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
11. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 At the ... has granted a 60-day extension for the public comment ... Special Rule for Model Aircraft established by Congress as ... 2012. The 60-day extension establishes the new deadline for ... States Department of Transportation/FAA notice published in the Federal ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... July 24, 2014 Gain recognition ... Supply Chain of the biotech industry. Nominations are ... Awards, brought to you by the Bio ... of supply chain management professionals for the past ... stakeholders of the Biotech industry – Manufacturers, Service ...
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... presentation to investors on Tuesday, July 29, 2014, ... presentation will include an overview of Asterias, business ... webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 ...
Breaking Biology Technology:FAA Grants Comment Extension at the Request of AMA 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... ThirdBiotech,( http://www.thirdbiotech.com ), a biotechnology networking ... in Arizona. (Logo: http://www.newscom.com/cgi-bin/prnh/20070911/LATU119LOGO ) ... the group to foster,networking and collaboration for ... the state. "It,s important we start finding ...
... 11 Dynatronics,Corporation (Nasdaq: DYNT ) will ... ended June 30, 2007 during the morning of ... conference call for investors later that,day at 1:00 ... quarter and fiscal year.,Those interested in participating should ...
... DALLAS, Sept. 11 ACCESS PHARMACEUTICALS, INC.,(OTC ... business columnist,Gene Marcial of BusinessWeek, highlighted Access ... 17, 2007. The article is also available,on ... Street, column. The article focused upon ...
Cached Biology Technology:Access Highlighted in Recent BusinessWeek Article 2
(Date:7/25/2014)... 25, 2014 Biometrics industry expands ... to digital technology for online & commerce payments while ... (NASDAQ: GOOG ), LifeLock Inc. (NYSE: ... ), Apple Inc. (NASDAQ: AAPL ) and ... NXTD) a biometric authentication company focused on the growing ...
(Date:7/24/2014)... 2014 /PRNewswire-iReach/ -- The Geneva Healthcare Suite, an innovative ... cut emergency room wait times by an average of ... Center, according to a recent study published in the ... using the suite to access data from incoming patients, ... "Using Geneva,s technology platform we have been able ...
(Date:7/24/2014)... effects on different species of fish, according to ... and Exeter which tested fish anti-predator behaviour. ... seagull predator model when exposed to additional noise, ... , Lead author Dr Irene Voellmy of ... in many aquatic environments have increased substantially during ...
Breaking Biology News(10 mins):Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
... many good things into the world: efficient solar power, ... in biomedical imaging among them. But they ... Rice researchers has been working to discover the health ... generally composed of heavy metals surrounded by an organic ...
... ARTICLE #1 FOR IMMEDIATE RELEASE Edible fungus ... Food Chemistry Scientists in Florida report that ... help to reduce the serious side effects that can ... juice. Their study is in the January 14 edition ...
... most dependent on fish imports. This situation is due in part ... collapse of fish stocks, which have also been observed in Sweden. ... and high prices lead to a decrease in consumption, which in ... healthy diet. The fact that we make use of fish stocks ...
Cached Biology News:Rice eyes risks of quantum dots 2American Chemical Society's Weekly PressPac -- Jan. 28, 2009 2American Chemical Society's Weekly PressPac -- Jan. 28, 2009 3American Chemical Society's Weekly PressPac -- Jan. 28, 2009 4American Chemical Society's Weekly PressPac -- Jan. 28, 2009 5American Chemical Society's Weekly PressPac -- Jan. 28, 2009 6Research project to boost European fish farming 2
Bovine Serum Albumin Heat Shock Diagnostic Grade Powder...
MpV17 transgene, murine homolog, glomerulosclerosis...
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Silencer Pre-designed siRNAs, which are already designed ...
Human SDNSF/MCFD2 Biotinylated Affinity Purified PAb...
Biology Products: